Nyxoah SA
NYXH4.650USD
+0.060+1.31%
終値 02/06, 16:00（ET）15分遅れの株価
174.58M時価総額
損失額直近12ヶ月PER
詳細情報 Nyxoah SA 企業名
Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.
Nyxoah SAの企業情報
企業コードNYXH
会社名Nyxoah SA
上場日Sep 18, 2020
最高経営責任者「CEO」Taelman (Olivier)
従業員数- -
証券種類Ordinary Share
決算期末Sep 18
本社所在地Rue Edouard Belin 12
都市MONT-SAINT-GUIBERT
証券取引所NASDAQ OMX - NASDAQ BASIC
国Belgium
郵便番号1435
電話番号3226121755
ウェブサイトhttps://www.nyxoah.com/
企業コードNYXH
上場日Sep 18, 2020
最高経営責任者「CEO」Taelman (Olivier)
Nyxoah SAの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Robert Taub
Mr. Robert Taub
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
4.31M
+70000.00%
Mr. Kevin L. Rakin
Mr. Kevin L. Rakin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Juergen Hambrecht, Ph.D.
Dr. Juergen Hambrecht, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Rita F. Johnson-Mills
Ms. Rita F. Johnson-Mills
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Pierre Gianello, M.D.
Dr. Pierre Gianello, M.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Olivier Taelman
Mr. Olivier Taelman
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Mr. Christoph Eigenmann
Mr. Christoph Eigenmann
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Daniel G. Wildman
Mr. Daniel G. Wildman
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Francis Kim
Mr. Francis Kim
Chief Regulatory and Quality Officer
Chief Regulatory and Quality Officer
--
--
Dr. Maurits S. Boon
Dr. Maurits S. Boon
Chief Medical Officer
Chief Medical Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Robert Taub
Mr. Robert Taub
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
4.31M
+70000.00%
Mr. Kevin L. Rakin
Mr. Kevin L. Rakin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Juergen Hambrecht, Ph.D.
Dr. Juergen Hambrecht, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Rita F. Johnson-Mills
Ms. Rita F. Johnson-Mills
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Pierre Gianello, M.D.
Dr. Pierre Gianello, M.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Olivier Taelman
Mr. Olivier Taelman
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
収益内訳
会社から関連データがまだ開示されていません。
会社から関連データがまだ開示されていません。
事業別
地域別
会社から関連データがまだ開示されていません。
株主
更新時刻: Sun, Jan 18
更新時刻: Sun, Jan 18
株主統計
種類
株主統計
株主統計
比率
Cochlear Limited
13.59%
Taub (Robert)
10.02%
Monden (Anneliese)
6.83%
Gilde Healthcare Partners B.V.
6.83%
ResMed Inc
4.02%
他の
58.72%
株主統計
株主統計
比率
Cochlear Limited
13.59%
Taub (Robert)
10.02%
Monden (Anneliese)
6.83%
Gilde Healthcare Partners B.V.
6.83%
ResMed Inc
4.02%
他の
58.72%
種類
株主統計
比率
Individual Investor
19.98%
Corporation
17.61%
Investment Advisor
8.68%
Venture Capital
7.02%
Investment Advisor/Hedge Fund
5.74%
Hedge Fund
0.63%
Research Firm
0.17%
他の
40.19%
機関投資家保有株
更新時刻: Thu, Jan 1
更新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
80
9.57M
22.23%
+53.45K
2025Q3
74
8.21M
21.94%
-2.04M
2025Q2
69
25.16M
67.22%
-3.01M
2025Q1
70
26.40M
70.53%
-2.65M
2024Q4
73
25.60M
68.47%
-1.01M
2024Q3
72
23.51M
71.46%
-828.78K
2024Q2
72
23.54M
72.39%
-1.11M
2024Q1
64
20.89M
72.68%
+374.51K
2023Q4
59
21.08M
73.36%
-418.05K
2023Q3
66
19.86M
69.10%
-2.56M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Cochlear Limited
5.85M
13.59%
+215.96K
+3.84%
Nov 20, 2025
Taub (Robert)
4.31M
10.02%
+70.00K
+1.65%
Dec 01, 2025
Monden (Anneliese)
2.94M
6.83%
--
--
Dec 31, 2024
Gilde Healthcare Partners B.V.
2.94M
6.83%
--
--
Dec 31, 2024
ResMed Inc
1.73M
4.02%
--
--
Dec 31, 2024
BNP Paribas Asset Management Belgium S.A.
732.78K
1.7%
--
--
Nov 30, 2025
Hambrecht (Jürgen)
1.34M
3.12%
--
--
Dec 31, 2024
Vestal Point Capital, LP
1.11M
2.57%
-294.59K
-21.01%
Sep 30, 2025
Heights Capital Management, Inc.
831.43K
1.93%
+831.43K
--
Dec 18, 2025
BlackRock Financial Management, Inc.
647.21K
1.5%
-36.44K
-5.33%
Sep 30, 2025
詳細を見る
関連ETF
更新時刻: Tue, Dec 2
更新時刻: Tue, Dec 2
銘柄名
比率
iShares Health Innovation Active ETF
0.09%
Avantis International Equity ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
SPDR Portfolio Europe ETF
0%
DFA Dimensional International Small Cap ETF
0%
Avantis International Small Cap Equity ETF
0%
iShares Health Innovation Active ETF
比率0.09%
Avantis International Equity ETF
比率0%
DFA Dimensional International Core Equity 2 ETF
比率0%
SPDR Portfolio Europe ETF
比率0%
DFA Dimensional International Small Cap ETF
比率0%
Avantis International Small Cap Equity ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
